newsfilter
← Latest News
Business Wire·

TCT 2022: Impella Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery

Abiomed (NASDAQ:ABMD) will highlight how Impella heart pumps help heart teams achieve more complete high-risk revascularization and heart recovery in the catheterization lab and operating room at the Transcatheter Cardiovascular Therapeutics (TCT) 2022